Physician profile
Udit Rajeev Joshi
NPI 1073966982
$12,116.21
in general payments reported to CMS, 2019-2025
36 companies · $468 in 2025
The $468 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $572 · 2020: $395 · 2021: $1,226 · 2022: $3,570 · 2023: $4,297 · 2024: $1,588 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,353.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,140.97 | 2020-2024 | Dragonfly Opstar, Pressurewire, Xience Skypoint |
| Shockwave Medical, INC | $1,581.59 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $1,127.29 | 2022-2025 | Impella |
| Terumo Medical Corporation | $720.16 | 2022-2023 | Metacross Otw, Angio-Seal, Glidesheath Slender |
| Boston Scientific Corporation | $601.76 | 2021-2024 | Varithena Administration Pack |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $570.50 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $549.39 | 2019-2023 | Xarelto |
| Inari Medical, INC. | $529.98 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $526.96 | 2022-2023 | Venovo, Crosser Iq, Lutonix Drug Coated Balloon |
| Medtronic, INC. | $514.44 | 2021-2024 | In.Pact Admiral, Hawkone, Abre |
| Cordis US Corp. | $249.58 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $246.55 | 2022-2025 | Farxiga, Wainua |
| Chiesi USA, INC. | $221.26 | 2021-2023 | Kengreal |
| Amgen INC. | $218.00 | 2022-2023 | Repatha |
| Teleflex LLC | $214.89 | 2022-2023 | Trapliner, Venture, Turnpike |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $203.34 | 2024-2025 | Assure Wcd |
| Medtronic Vascular, INC. | $199.81 | 2019 | |
| Cardiovascular Systems INC. | $170.88 | 2021-2022 | |
| Cvrx, INC. | $170.58 | 2024 | Barostim Neo System |
| Pfizer INC. | $157.83 | 2022-2025 | |
| Stryker Corporation | $148.64 | 2025 | Flowtriever |
| E.R. Squibb & Sons, L.L.C. | $147.48 | 2022-2025 | Camzyos, Eliquis |
| Cook Medical LLC | $146.68 | 2023-2024 | Advance, Torcon Nb, Zilver Vena |
| Novartis Pharmaceuticals Corporation | $129.99 | 2022-2025 | |
| Philips North America LLC | $116.51 | 2022-2023 | |
| Cagent Vascular INC | $100.24 | 2023 | Serrantor |
| Kiniksa Pharmaceuticals International, Plc | $72.64 | 2024 | Arcalyst |
| W. L. Gore & Associates, INC. | $63.66 | 2022-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Cardiva Medical, INC. | $52.90 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Merck Sharp & Dohme LLC | $52.18 | 2024-2025 | Verquvo, Winrevair, Capvaxive |
| Getinge USA Sales, LLC | $51.58 | 2021 | |
| Heartflow, INC. | $29.76 | 2022 | |
| Surmodics, INC. | $28.20 | 2023 | Pounce Venous Thrombectomy System, Pounce Thrombectomy System, Pounce Thrombectomy |
| Alnylam Pharmaceuticals INC. | $27.32 | 2025 | Amvuttra |
| Asahi Intecc USA, INC. | $19.55 | 2022 | |
| Irhythm Technologies, INC. | $13.12 | 2024 | Zio Monitor, Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Udit Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.